Welcome to our dedicated page for Phibro Animal SEC filings (Ticker: PAHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Phibro Animal Health Corporation filings document current reports for an animal health and mineral nutrition operating company with Class A common stock registered on Nasdaq. Recent Form 8-K disclosures cover operating results and financial guidance, quarterly dividends on Class A and Class B common stock, and amendments to the company’s credit agreement.
The filing record also includes Regulation FD disclosure about Brazilian rules for performance enhancing feed additives containing antimicrobials, including virginiamycin and bacitracin, and governance reports covering board and executive leadership changes. These filings frame PAHC’s disclosure record around operating performance, capital allocation, debt capacity, product regulation and public-company governance.